Publications by authors named "M Laffan"

Claim this Profile
O
Outcomes and Healthcare Resource Utilisation in Adults With von Willebrand Disease Receiving On-Demand Recombinant von Willebrand Factor in the United Kingdom.
Mike Laffan, Heena Howitt, Cheryl Jones, Sarah Brighton, Rosa Willock

Eur J Haematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and Healthcare Resource Utilisation in Adults With von Willebrand Disease Treated With Recombinant von Willebrand Factor in Surgical Settings in the United Kingdom.
Mike Laffan, Heena Howitt, Cheryl Jones, Sarah Brighton, Rosa Willock

Eur J Haematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel in vitro model of trauma-induced endotheliopathy provides a platform for studying mechanisms of coagulopathy.
Jeries Abu-Hanna, Gang Xu, Gael B Morrow, Lewis Timms, Naveed Akbar, Mike Laffan

Blood Vessel Thromb Hemost· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitioning of Patients from Direct-Acting Oral Anticoagulant to Heparin: Impact on Laboratory Testing.
Deepa J Arachchillage, Saravanan Vinayagam, Annie Parsons, Nilanthi Karawitage, Mike Laffan

Semin Thromb Hemost· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory practice on detection of antiphospholipid antibodies: UK NEQAS blood coagulation survey-2024.
Deepa J Arachchillage, Mike Laffan, Will Lester, Steve Kitchen, Ian Jennings

Br J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis